◀ Back to TGFB1
TGFB1 — TGFBR1
Pathways - manually collected, often from reviews:
-
OpenBEL Selventa BEL large corpus:
TGFBR1
→
TGFB1
(directlyIncreases, TGFB1 Activity)
Evidence: the SGK promoter contains consensus DNA elements for Smad and Fast-1 binding (hatched boxes labeled SMAD 3/4 and Fast-1 in figure 2) that are activated by TGF-beta receptor signaling, This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the associatio...
-
OpenBEL Selventa BEL large corpus:
TGFB1
→
TGFBR1
(increases, TGFB1 Activity)
Evidence: Although the growth-inhibitory effect of TGF-B is believed to be mediated by the Smad dependent TGF-B signaling pathway, there have been reports of TGF-B mediated inhibition of proliferation in Smad4 null cells.22 Proposed alternative mechanisms for resistance to TGF-B include decreased expression of TBRI,34 TBRII,35 or TBRIII36 on the cell surface; increased expression of the inhibitory Smad, Smad7; repression of TGF-B signaling by a variety of oncoproteins including p53,38 Myc,39 E1A,40 Ras,41...
-
OpenBEL Selventa BEL large corpus:
TGFBR1
→
Complex of TGFB1-TGFBR1
(directlyIncreases, TGFB1/TGFBR1 Activity)
Evidence: the SGK promoter contains consensus DNA elements for Smad and Fast-1 binding (hatched boxes labeled SMAD 3/4 and Fast-1 in figure 2) that are activated by TGF-beta receptor signaling, This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the associatio...
-
OpenBEL Selventa BEL large corpus:
TGFBR1
→
Complex of TGFB1-TGFBR1-TGFBR2
(directlyIncreases, TGFB1/TGFBR1/TGFBR2 Activity)
Evidence: TGF-B1 is the most abundant and universally expressed isoform; most studies have either examined or been performed with exogenous TGF-B1. TGF-B is secreted into the extracellular matrix as a latent protein complex bound to a latency- associated protein and one of the four isoforms of latent TGF-B binding protein. Activation of TGF-B, which is required for biologic activity, occurs through poorly understood mechanisms likely involving proteolytic processing of the associated proteins and release ...
-
OpenBEL Selventa BEL large corpus:
Complex of TGFB1-TGFBR1
→
MMP9
(increases, TGFB1/TGFBR1 Activity)
Evidence: TGF-{beta} is activated by MMP-9...TGF-{beta} causes small airway fibrosis and also activates MMP-9.
-
BioCarta tgf beta signaling pathway:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta (TGFB1/TGFB2/TGFB3)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta-R1 (TGFBR1)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
TGF-beta (TGFB1/TGFB2/TGFB3)
→
TGF-beta-R1 (TGFBR1)
(modification, collaborate)
-
BioCarta ctcf: first multivalent nuclear factor:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta/TGF-beta/TGF-beta-R1/TGF-beta-R1/TGF-beta-R2/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
MADH7 (SMAD7)
→
TGF-beta/TGF-beta/TGF-beta-R1/TGF-beta-R1/TGF-beta-R2/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, inhibits)
-
BioCarta tgf beta signaling pathway:
SMAD2/SARA complex (SAR1A-SMAD2)
→
TGF-beta/TGF-beta/TGF-beta-R1/TGF-beta-R1/TGF-beta-R2/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, collaborate)
-
BioCarta nfkb activation by nontypeable hemophilus influenzae:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta (TGFB1/TGFB2/TGFB3)
(modification, collaborate)
-
BioCarta nfkb activation by nontypeable hemophilus influenzae:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta-R1/TGF-beta-R2 complex (TGFBR1-TGFBR2)
(modification, collaborate)
-
BioCarta nfkb activation by nontypeable hemophilus influenzae:
TGF-beta (TGFB1/TGFB2/TGFB3)
→
TGF-beta-R1/TGF-beta-R2 complex (TGFBR1-TGFBR2)
(modification, collaborate)
-
BioCarta ctcf: first multivalent nuclear factor:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, collaborate)
-
BioCarta ctcf: first multivalent nuclear factor:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta-R2 (TGFBR2)
(modification, collaborate)
-
BioCarta ctcf: first multivalent nuclear factor:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta-R2 (TGFBR2)
(modification, collaborate)
-
BioCarta alk in cardiac myocytes:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta (TGFB1/TGFB2/TGFB3)
(modification, collaborate)
-
BioCarta alk in cardiac myocytes:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta-R1 (TGFBR1)
(modification, collaborate)
-
BioCarta alk in cardiac myocytes:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta-R2 (TGFBR2)
(modification, collaborate)
-
BioCarta alk in cardiac myocytes:
TGF-beta (TGFB1/TGFB2/TGFB3)
→
TGF-beta-R1 (TGFBR1)
(modification, collaborate)
-
BioCarta ctcf: first multivalent nuclear factor:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta (TGFB1/TGFB2/TGFB3)
(modification, collaborate)
-
BioCarta ctcf: first multivalent nuclear factor:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta-R1 (TGFBR1)
(modification, collaborate)
-
BioCarta ctcf: first multivalent nuclear factor:
TGF-beta (TGFB1/TGFB2/TGFB3)
→
TGF-beta-R1 (TGFBR1)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta/TGF-beta/TGF-beta-R1/TGF-beta-R1/TGF-beta-R2/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
MADH7 (SMAD7)
→
TGF-beta/TGF-beta/TGF-beta-R1/TGF-beta-R1/TGF-beta-R2/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, inhibits)
-
BioCarta nfkb activation by nontypeable hemophilus influenzae:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
SMAD3
(modification, activates)
-
BioCarta tgf beta signaling pathway:
TAB1 (MAP3K7IP1)
→
TGF-beta/TGF-beta/TGF-beta-R1/TGF-beta-R1/TGF-beta-R2/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
NR2C2
→
TGF-beta/TGF-beta/TGF-beta-R1/TGF-beta-R1/TGF-beta-R2/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
TGF-beta/TGF-beta R1 complex (TGFB1_TGFB2_TGFB3-TGFBR1)
→
TGF-beta-R2 (TGFBR2)
(modification, collaborate)
-
BioCarta tgf beta signaling pathway:
TGF-beta/TGF-beta-R1/TGF-beta-R2 complex (TGFB1_TGFB2_TGFB3-TGFBR2-TGFBR1)
→
TGF-beta-R2 (TGFBR2)
(modification, collaborate)
-
KEGG Osteoclast differentiation:
TGFB1/TGFB2
→
TGFBR1/TGFBR2
(protein-protein, activation)
-
KEGG MAPK signaling pathway:
TGFB1/TGFB2/TGFB3
→
TGFBR1/TGFBR2
(protein-protein, activation)
-
KEGG Pathways in cancer:
TGFB1/TGFB2/TGFB3
→
Complex of TGFBR1-TGFBR2
(protein-protein, activation)
-
KEGG Pancreatic cancer:
TGFB1/TGFB2/TGFB3
→
Complex of TGFBR1-TGFBR2
(protein-protein, activation)
-
KEGG Chronic myeloid leukemia:
TGFB1/TGFB2/TGFB3
→
Complex of TGFBR1-TGFBR2
(protein-protein, activation)
-
KEGG Cytokine-cytokine receptor interaction:
TGFB1
→
Complex of TGFBR1-TGFBR2
(protein-protein, activation)
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CK2B complex (TGFBR2-TGFBR1-ACVRL1-CSNK2B-ENG-TGFB1)
→
FKBP12 (FKBP1A)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CK2B complex (TGFBR2-TGFBR1-ACVRL1-CSNK2B-ENG-TGFB1)
→
CK2B/FKBP12/ALK1 (dimer) complex (FKBP1A-ACVRL1-CSNK2B)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CK2B complex (TGFBR2-TGFBR1-ACVRL1-CSNK2B-ENG-TGFB1)
→
FKBP12/TGFBR1 (dimer) complex (TGFBR1-FKBP1A)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CK2B complex (TGFBR2-TGFBR1-ACVRL1-CSNK2B-ENG-TGFB1)
→
TGFB1/TGFBR2/Endoglin (dimer) complex (TGFBR2-ENG-TGFB1)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
FKBP12/TGFBR1 (dimer) complex (TGFBR1-FKBP1A)
→
TGFB1/TGFBR2/Endoglin (dimer) complex (TGFBR2-ENG-TGFB1)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CK2B complex (TGFBR2-TGFBR1-ACVRL1-CSNK2B-ENG-TGFB1)
→
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
(modification, activates)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CK2B complex (TGFBR2-TGFBR1-ACVRL1-CSNK2B-ENG-TGFB1)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, activates)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
Caveolin-1 (CAV1)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CAV1 complex (TGFBR2-TGFBR1-ACVRL1-CAV1-ENG-TGFB1)
(modification, collaborate)
Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database ALK1 signaling events:
Caveolin-1 (CAV1)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
(modification, collaborate)
Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CAV1 complex (TGFBR2-TGFBR1-ACVRL1-CAV1-ENG-TGFB1)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
(modification, collaborate)
Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Glypican 1 network:
TGFB family (dimer) (TGFB3/TGFB1)
→
TGFBR1 (dimer) complex (TGFBR1)
(modification, collaborate)
Li et al., Biochem Biophys Res Commun 2004
Evidence: mutant phenotype, other species
-
NCI Pathway Database Glypican 1 network:
TGFB family (dimer) (TGFB3/TGFB1)
→
GPC1/TGFB/TGFBR1/TGFBR2 complex (TGFBR1-GPC1-TGFBR2)
(modification, collaborate)
Li et al., Biochem Biophys Res Commun 2004
Evidence: mutant phenotype, other species
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CAV1 complex (TGFBR2-TGFBR1-ACVRL1-CAV1-ENG-TGFB1)
→
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
(modification, activates)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Valdimarsdottir et al., BMC cell biology 2006, Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CAV1 complex (TGFBR2-TGFBR1-ACVRL1-CAV1-ENG-TGFB1)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/PPP1CA complex (TGFBR2-TGFBR1-ACVRL1-PPP1CA-ENG-TGFB1)
(modification, activates)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Valdimarsdottir et al., BMC cell biology 2006, Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/CAV1 complex (TGFBR2-TGFBR1-ACVRL1-CAV1-ENG-TGFB1)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, activates)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Valdimarsdottir et al., BMC cell biology 2006, Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/PPP1CA complex (TGFBR2-TGFBR1-ACVRL1-PPP1CA-ENG-TGFB1)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, inhibits)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Valdimarsdottir et al., BMC cell biology 2006, Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
PPP1CA (PPP1CA)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/PPP1CA complex (TGFBR2-TGFBR1-ACVRL1-PPP1CA-ENG-TGFB1)
(modification, collaborate)
Valdimarsdottir et al., BMC cell biology 2006
Evidence: physical interaction
-
NCI Pathway Database ALK1 signaling events:
PPP1CA (PPP1CA)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
(modification, collaborate)
Valdimarsdottir et al., BMC cell biology 2006
Evidence: physical interaction
-
NCI Pathway Database ALK1 signaling events:
SMAD7 (SMAD7)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/PPP1CA complex (TGFBR2-TGFBR1-ACVRL1-PPP1CA-ENG-TGFB1)
(modification, activates)
Valdimarsdottir et al., BMC cell biology 2006
Evidence: physical interaction
-
NCI Pathway Database ALK1 signaling events:
SMAD7 (SMAD7)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
(modification, activates)
Valdimarsdottir et al., BMC cell biology 2006
Evidence: physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1/PPP1CA complex (TGFBR2-TGFBR1-ACVRL1-PPP1CA-ENG-TGFB1)
→
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
(modification, collaborate)
Valdimarsdottir et al., BMC cell biology 2006
Evidence: physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
→
FKBP12 (FKBP1A)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
→
FKBP12/TGFBR1 (dimer) complex (TGFBR1-FKBP1A)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
→
FKBP12/ALK1 (dimer) complex (FKBP1A-ACVRL1)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
TGFB1/TGFBR2/Endoglin/TGFBR1/ALK1 complex (TGFBR2-TGFBR1-ACVRL1-ENG-TGFB1)
→
TGFB1/TGFBR2/Endoglin (dimer) complex (TGFBR2-ENG-TGFB1)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
FKBP12/TGFBR1 (dimer) complex (TGFBR1-FKBP1A)
→
TGFB1/TGFBR2/Endoglin (dimer) complex (TGFBR2-ENG-TGFB1)
(modification, collaborate)
Lux et al., J Biol Chem 1999, Goumans et al., Mol Cell 2003, Blanco et al., J Cell Physiol 2005, Attisano et al., Cell 1993, Wang et al., Cell 1996
Evidence: mutant phenotype, assay, physical interaction
-
Reactome Reaction:
TGFB1
→
TGFBR1
(reaction)
Wu et al., Science 2000, Tanaka et al., Br J Cancer 2000*, Souchelnytskyi et al., Methods Mol Biol 2001, Kavsak et al., Mol Cell 2000, Ebisawa et al., J Biol Chem 2001, Wrana et al., Cell 1992, Shi et al., J Cell Biol 2004, Kuratomi et al., Biochem J 2005, Ozdamar et al., Science 2005, Wicks et al., Oncogene 2005, Kang et al., Nat Cell Biol 2008*, Zhang et al., Cell Res 2010*, Goudie et al., Nat Genet 2011*, Eichhorn et al., Nat Med 2012, Fleming et al., Cancer Res 2013, Moustakas et al., J Biol Chem 1993, Wrana et al., Nature 1994, Franzén et al., Cell 1993, Souchelnytskyi et al., EMBO J 1996, Chen et al., EMBO J 1997, Grady et al., Cancer Res 1999*
-
Reactome Reaction:
TGFB1
→
TGFBR1
(indirect_complex)
Wu et al., Science 2000, Tanaka et al., Br J Cancer 2000*, Souchelnytskyi et al., Methods Mol Biol 2001, Wrana et al., Cell 1992, Kang et al., Nat Cell Biol 2008*, Zhang et al., Cell Res 2010*, Goudie et al., Nat Genet 2011*, Fleming et al., Cancer Res 2013, Moustakas et al., J Biol Chem 1993, Wrana et al., Nature 1994, Franzén et al., Cell 1993, Souchelnytskyi et al., EMBO J 1996, Hayashi et al., Cell 1997, Chen et al., EMBO J 1997, Nakao et al., Nature 1997, Tsukazaki et al., Cell 1998, Grady et al., Cancer Res 1999*
-
WikiPathways Extracellular vesicle-mediated signaling in recipient cells:
TGFB1/TGFB2/TGFB3
→
TGFBR1/TGFBR3
(activation)
-
WikiPathways Hepatitis C and Hepatocellular Carcinoma:
TGFB1
→
TGFBR1
(activation)
-
WikiPathways MAPK Signaling Pathway:
TGFB2/TGFB1/TGFB3
→
ACVR1C/ACVR1B/TGFBR1/TGFBR2
(activation)
-
WikiPathways TGF-beta Receptor Signaling:
TGFB1/INHBA
→
TGFBR1
(activation)
-
WikiPathways Canonical and Non-Canonical TGF-B signaling:
TGFB1
→
Complex of TGFBR1-TGFBR2
(mim-binding)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind Interaction:
TGFB1
—
TGFBR1
Lin et al., J Biol Chem 1995
-
IRef Bind_translation Interaction:
TGFB1
—
TGFBR1
(cross-linking study)
Lin et al., J Biol Chem 1995
-
IRef Biogrid Interaction:
TGFB1
—
TGFBR1
(physical association, affinity chromatography technology)
Oh et al., Proc Natl Acad Sci U S A 2000
-
IRef Biogrid Interaction:
TGFB1
—
TGFBR1
(physical association, affinity chromatography technology)
Ebner et al., Science 1993*
-
MIPS CORUM TGF-beta receptor II-TGF-beta receptor I-TGF-beta1 complex:
TGF-beta receptor II-TGF-beta receptor I-TGF-beta1 complex complex (TGFB1-TGFBR1-TGFBR2)
Zúñiga et al., J Mol Biol 2005*
-
IRef Corum Interaction:
Complex of TGFBR2-TGFBR1-TGFB1-TGFBR2-TGFBR1-TGFB1-TGFBR1-TGFBR2-TGFB1
(association, anti bait coimmunoprecipitation)
Yamashita et al., J Biol Chem 1994*
-
IRef Dip Interaction:
TGFB1
—
TGFBR1
(physical association, coimmunoprecipitation)
Vivien et al., J Biol Chem 1995*
-
IRef Dip Interaction:
TGFB1
—
TGFBR1
(physical association, biochemical)
Lux et al., J Biol Chem 1999
-
IRef Hprd Interaction:
TGFBR1
—
TGFB1
(in vivo)
Ebner et al., Science 1993*
-
IRef Intact Interaction:
TGFB1
—
TGFBR1
(direct interaction, cross-linking study)
Pardali et al., Oncogene 2011*
-
IRef Ophid Interaction:
TGFB1
—
TGFBR1
(aggregation, confirmational text mining)
Ebner et al., Science 1993*
-
IRef Ophid Interaction:
TGFB1
—
TGFBR1
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
Text-mined interactions from Literome
Piek et al., Int J Cancer 1999
(Glioblastoma...) :
Interestingly,
TGF-beta1 differentially stimulated or
inhibited the expression of
TbetaR-I and TbetaR-II mRNA in the gliomas
Zieske et al., Invest Ophthalmol Vis Sci 2001
:
To determine the
effect of epidermal growth factor (EGF) and
TGF-beta1 on p15(INK4b) and
TbetaR-I and -II expression, human corneal epithelial cells were grown in culture to 50 % to 60 % confluence, and EGF ( 5 ng/ml ) and/or TGF-beta1 ( 2 ng/ml ) were added for 6 hours ... In cultured cells, EGF and
TGF-beta1 stimulated TbetaR-II ; however, neither one stimulated
TbetaR-I expression
Lindstedt et al., FASEB J 2001
:
In isolated
TbetaRI- and TbetaRII expressing peritoneal macrophages, the activated
TGF-beta1 induces the expression of the plasminogen activator inhibitor 1 ( PAI-1 ), whereas in the mast cells, the levels of TbetaRI, TbetaRII, and PAI-1 expression were below detection
Karlsson et al., Physiol Genomics 2005
:
Gene expression profiling demonstrates that
TGF-beta1 signals exclusively through receptor complexes
involving Alk5 and identifies targets of TGF-beta signaling
Birukova et al., FEBS Lett 2005
:
Thus, our data demonstrate for the first time direct link between
TGF-beta1 mediated activation of
ALK5/Smad and EC barrier dysfunction
Jeon et al., J Cell Sci 2006
:
In addition, SPC increased secretion of
TGF-beta1 through an ERK dependent pathway, and the SPC induced expression of alpha-SMA and delayed phosphorylation of Smad2 were
blocked by SB-431542, a
TGF-beta type I receptor kinase inhibitor, or anti-TGF-beta1 neutralizing antibody
Matsuzaki et al., Hepatology 2007
(Carcinoma, Hepatocellular...) :
Conversely,
transforming growth factor beta ( TGF-beta )
activates not only
TGF-beta type I receptor ( TbetaRI ) but also c-Jun N-terminal kinase (JNK), which convert the mediator Smad3 into two distinctive phosphoisoforms : C-terminally phosphorylated Smad3 ( pSmad3C ) and linker phosphorylated Smad3 ( pSmad3L )
Velasco et al., J Cell Sci 2008
:
L- and S-endoglin differentially modulate
TGFbeta1 signaling
mediated by ALK1 and
ALK5 in L6E9 myoblasts
Alfranca et al., Blood 2008
:
MT1-MMP dependent
transforming growth factor beta ( TGFbeta ) signaling through Alk5 is also required for PGE ( 2 ) -induced endothelial cord formation in vitro, and
Alk5 kinase activity is
required for PGE ( 2 ) -induced neovascularization in vivo
Lu et al., Am J Physiol Lung Cell Mol Physiol 2009
:
Finally, we noted that SMAD1/5 were activated upon
ALK5 inhibition in the
presence of low levels of
TGF-beta1 , an effect associated with enhanced endothelial proliferation
Kim et al., J Biol Chem 2009
:
Taken together, our data indicate that
TGF-beta1 induced interaction of
TbetaRI and TbetaRII triggers dissociation of TAK1 from TbetaRI, and subsequently TAK1 is phosphorylated through TAB1 mediated autophosphorylation and not by the receptor kinase activity of TbetaRI
Li et al., J Biol Chem 2010
:
Formation of a stable KLF4-Smad2 complex in the promoter 's Smad-responsive region mediated cooperative
TbetaRI promoter transcription in
response to
TGF-beta1
Souchelnytskyi et al., EMBO J 1996
:
We show here that phosphorylation of
TbetaR-I at Ser165 is
involved in modulation of
TGF-beta1 signaling
Persson et al., J Biol Chem 1997
:
In the
presence of
TGF-beta1 , TbetaR-I/BMPR-IB and TbetaR-II/ActR-IIB formed heteromeric complexes with wild-type TbetaR-II and
TbetaR-I , respectively, upon stable transfection in mink lung epithelial cell lines
Kleeff et al., J Biol Chem 1998
(Pancreatic Neoplasms) :
The protein synthesis inhibitor cycloheximide ( 10 microg/ml ) completely blocked the
TGF-beta1 mediated increase in
TbetaRI and TbetaRII expression